Literature DB >> 9770121

The pivotal role of VEGF in tumor angiogenesis: molecular facts and therapeutic opportunities.

G Siemeister1, G Martiny-Baron, D Marmé.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9770121     DOI: 10.1023/a:1006027124696

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


× No keyword cloud information.
  12 in total

Review 1.  [Role of receptor tyrosine kinase in the angiogenesis].

Authors:  S Meyer; C Hafner; T Vogt
Journal:  Hautarzt       Date:  2002-09       Impact factor: 0.751

2.  Molecular profiling of angiogenic markers: a step towards interpretive analysis of a complex biological function.

Authors:  Kevin P Claffey
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

3.  Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas.

Authors:  M Detmar; P Velasco; L Richard; K P Claffey; M Streit; L Riccardi; M Skobe; L F Brown
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

Review 4.  Smad4 transcriptional pathways and angiogenesis.

Authors:  Irmgard Schwarte-Waldhoff; Wolff Schmiegel
Journal:  Int J Gastrointest Cancer       Date:  2002

5.  A novel mechanism of repression of the vascular endothelial growth factor promoter, by single strand DNA binding cold shock domain (Y-box) proteins in normoxic fibroblasts.

Authors:  Leeanne S Coles; Peter Diamond; Lidia Lambrusco; Julie Hunter; Julie Burrows; Mathew A Vadas; Gregory J Goodall
Journal:  Nucleic Acids Res       Date:  2002-11-15       Impact factor: 16.971

6.  Angiogenesis and cathepsin expression are prognostic factors in pancreatic adenocarcinoma after curative resection.

Authors:  M Niedergethmann; R Hildenbrand; G Wolf; C S Verbeke; A Richter; S Post
Journal:  Int J Pancreatol       Date:  2000-08

Review 7.  Molecular pathways in bladder cancer.

Authors:  Stephen G Williams; John P Stein
Journal:  Urol Res       Date:  2004-11-13

8.  Lactate administration reproduces specific brain and liver exercise-related changes.

Authors:  Lezi E; Jianghua Lu; J Eva Selfridge; Jeffrey M Burns; Russell H Swerdlow
Journal:  J Neurochem       Date:  2013-08-26       Impact factor: 5.372

9.  Combining the multitargeted tyrosine kinase inhibitor vandetanib with the antiestrogen fulvestrant enhances its antitumor effect in non-small cell lung cancer.

Authors:  Jill M Siegfried; Christopher T Gubish; Mary E Rothstein; Cassandra Henry; Laura P Stabile
Journal:  J Thorac Oncol       Date:  2012-03       Impact factor: 15.609

10.  Synthesis and preclinical evaluation of [(11)C]PAQ as a PET imaging tracer for VEGFR-2.

Authors:  Erik Samén; Jan-Olov Thorell; Li Lu; Tetyana Tegnebratt; Lars Holmgren; Sharon Stone-Elander
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-14       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.